Skip to content
  • Home
  • About
    • Company Overview
    • Directors & Management
    • Corporate Governance
  • Development Strategy
  • Clinical Trials
    • IIH EVOLVE
      • Study Flyer
  • Investors
    • ASX Announcements
    • Company Reports
    • Presentations
    • Analyst Reports
    • Top Shareholders
    • Share Registry
    • Contacts
    • Publications
    • Fact Sheets
  • Media
    • Articles
  • Careers
    • Current Openings
  • Contact Us
Menu
  • Home
  • About
    • Company Overview
    • Directors & Management
    • Corporate Governance
  • Development Strategy
  • Clinical Trials
    • IIH EVOLVE
      • Study Flyer
  • Investors
    • ASX Announcements
    • Company Reports
    • Presentations
    • Analyst Reports
    • Top Shareholders
    • Share Registry
    • Contacts
    • Publications
    • Fact Sheets
  • Media
    • Articles
  • Careers
    • Current Openings
  • Contact Us

Author: anomaly

Invex Therapeutics makes progress ahead of IIH EVOLVE phase three clinical trial

Invex Therapeutics receives tax rebate for neurological drug research

Small Caps – Invex Therapeutics chases global registration of Presendin to treat idiopathic intracranial hypertension

Invex Therapeutics reports busy quarter in Presendin development

Small Caps – Invex Therapeutics signs major collaboration with Peptron

Invex Therapeutics closes busy quarter of development on Presendin for idiopathic intracranial hypertension

Invex Therapeutics receives US FDA feedback on planned Presendin trial targeting idiopathic intracranial hypertension

Small Caps – Invex Therapeutics pushes on with phase three trial design to repurpose drug for brain disorder

COVID-19 Impact on IIH – J Neurol article by Prof Alex Sinclair

JAMA Ophthalmology Publication – Alex Sinclair

← older

Partners

Contact Us

Address

Level 1, 38 Rowland St
Subiaco Perth WA 6008

Phone

+61 (08) 6382 0137

ACN

632145334

Email

info@invextherapeutics.com

Twitter Youtube Linkedin-in

Subscribe to our updates

Copyright © 2023 Invex Therapeutics. All rights reserved. Disclaimer.

Created by Anomaly.​

Menu
  • Home
  • About
    • Company Overview
    • Directors & Management
    • Corporate Governance
  • Development Strategy
  • Clinical Trials
    • IIH EVOLVE
      • Study Flyer
  • Investors
    • ASX Announcements
    • Company Reports
    • Presentations
    • Analyst Reports
    • Top Shareholders
    • Share Registry
    • Contacts
    • Publications
    • Fact Sheets
  • Media
    • Articles
  • Careers
    • Current Openings
  • Contact Us